• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种非线性生理药代动力学模型:I. 稳态

A nonlinear physiologic pharmacokinetic model: I. Steady-state.

作者信息

Wagner J G, Szpunar G J, Ferry J J

出版信息

J Pharmacokinet Biopharm. 1985 Feb;13(1):73-92. doi: 10.1007/BF01073657.

DOI:10.1007/BF01073657
PMID:4020623
Abstract

The two-compartment model of Rowland et al., (2) has been extended by replacing first order elimination with Michaelis-Menten elimination kinetics. All of the equations for steady-state concentrations and clearances for zero order (constant rate) input orally (into compartment #2) and intravenously (into compartment #1) are derived and reported. The steady-state concentration in compartment #1, following intravenous administration, is shown to be a nonlinear function of maximal velocity of metabolism, Vm, the Michaelis constant, Km, and liver blood flow, Q; and, following oral administration is dependent only upon Vm and Km and is independent of Q. However, oral bioavailability is a function of Vm, Km, and Q. The model allows physiologic pharmacokinetic interpretation of both linear and nonlinear data; and, together with simple modification of the model, can explain much observed pharmacokinetic data to date particularly for first-pass drugs. Future articles in the series will be concerned with single doses, evaluation of literature data in terms of the model, application of the theory in toxicology and in clinical pharmacokinetics and therapeutics.

摘要

罗兰等人(2)的二室模型已得到扩展,用米氏消除动力学取代了一级消除。推导并报告了口服(进入第2室)和静脉注射(进入第1室)零级(恒速)输入的稳态浓度和清除率的所有方程。静脉给药后,第1室的稳态浓度显示为代谢最大速度Vm、米氏常数Km和肝血流量Q的非线性函数;口服给药后,仅取决于Vm和Km,与Q无关。然而,口服生物利用度是Vm、Km和Q的函数。该模型允许对线性和非线性数据进行生理药代动力学解释;并且,通过对模型的简单修改,至今可以解释许多观察到的药代动力学数据,特别是对于首过效应药物。该系列的后续文章将涉及单剂量、根据模型对文献数据的评估、该理论在毒理学以及临床药代动力学和治疗学中的应用。

相似文献

1
A nonlinear physiologic pharmacokinetic model: I. Steady-state.一种非线性生理药代动力学模型:I. 稳态
J Pharmacokinet Biopharm. 1985 Feb;13(1):73-92. doi: 10.1007/BF01073657.
2
Michaelis-Menten elimination kinetics: areas under curves, steady-state concentrations, and clearances for compartment models with different types of input.米氏消除动力学:不同输入类型的房室模型的曲线下面积、稳态浓度和清除率
Biopharm Drug Dispos. 1985 Apr-Jun;6(2):177-200. doi: 10.1002/bdd.2510060209.
3
Saturable first-pass kinetics of propranolol.普萘洛尔的饱和首过动力学
J Clin Pharmacol. 1989 Mar;29(3):240-5. doi: 10.1002/j.1552-4604.1989.tb03320.x.
4
Comparison of nonlinear pharmacokinetic parameters estimated from the sinusoidal perfusion and venous equilibrium models.从正弦灌注模型和静脉平衡模型估算的非线性药代动力学参数的比较。
Biopharm Drug Dispos. 1985 Jan-Mar;6(1):23-31. doi: 10.1002/bdd.2510060104.
5
Relationships between steady-state and single-dose plasma drug concentrations for pharmacokinetic systems with nonlinear elimination.具有非线性消除的药代动力学系统中稳态与单剂量血浆药物浓度之间的关系。
Biopharm Drug Dispos. 1989 Sep-Oct;10(5):513-28. doi: 10.1002/bdd.2510100509.
6
Novel method of calculating absolute bioavailability in nonlinear pharmacokinetics.非线性药代动力学中计算绝对生物利用度的新方法。
J Pharm Sci. 1985 Jan;74(1):90-3. doi: 10.1002/jps.2600740125.
7
Pharmacokinetic properties of ethosuximide in monkeys. I. Single-dose intravenous and oral administration.乙琥胺在猴体内的药代动力学特性。I. 单剂量静脉注射和口服给药。
Epilepsia. 1975 Dec;16(5):705-16. doi: 10.1111/j.1528-1157.1975.tb04755.x.
8
Closed form solutions and dominant elimination pathways of simultaneous first-order and Michaelis-Menten kinetics.同时具有一级动力学和米氏动力学的封闭形式解及主要消除途径
J Pharmacokinet Pharmacodyn. 2015 Apr;42(2):151-61. doi: 10.1007/s10928-015-9407-3. Epub 2015 Feb 13.
9
First-pass effect: nonlinear concept comprising an explicit solution of integrated Michaelis-Menten equation.首过效应:非线性概念,包含米氏方程积分的显式解。
J Pharm Sci. 1981 Feb;70(2):195-8. doi: 10.1002/jps.2600700221.
10
First-pass elimination. Basic concepts and clinical consequences.首过消除。基本概念及临床后果。
Clin Pharmacokinet. 1984 Jan-Feb;9(1):1-25. doi: 10.2165/00003088-198409010-00001.

引用本文的文献

1
Accumulation kinetics of propranolol in the rat: comparison of Michaelis-Menten-mediated clearance and clearance changes consistent with the "altered enzyme hypothesis".普萘洛尔在大鼠体内的蓄积动力学:米氏介导清除率与符合“酶改变假说”的清除率变化的比较
Pharm Res. 1994 Mar;11(3):420-5. doi: 10.1023/a:1018921306200.
2
Identifiability and indistinguishability of nonlinear pharmacokinetic models.非线性药代动力学模型的可识别性与不可区分性
J Pharmacokinet Biopharm. 1994 Jun;22(3):229-51. doi: 10.1007/BF02353330.
3
Effect of protein binding on steady-state equations.

本文引用的文献

1
Statistical estimations in enzyme kinetics.酶动力学中的统计估计
Biochem J. 1961 Aug;80(2):324-32. doi: 10.1042/bj0800324.
2
Flow dependence of first-order uptake of substances by heterogeneous perfused organs.
J Theor Biol. 1980 Sep 21;86(2):365-76. doi: 10.1016/0022-5193(80)90012-0.
3
A method of determining intrinsic hepatic clearance from the first-pass effect.
Clin Exp Pharmacol Physiol. 1980 May-Jun;7(3):339-43. doi: 10.1111/j.1440-1681.1980.tb00080.x.
4
蛋白质结合对稳态方程的影响。
J Pharmacokinet Biopharm. 1985 Oct;13(5):559-60. doi: 10.1007/BF01059338.
4
Clinical significance of pharmacokinetic models of hepatic elimination.肝脏消除药代动力学模型的临床意义。
Clin Pharmacokinet. 1990 Jan;18(1):61-76. doi: 10.2165/00003088-199018010-00004.
On the location of cellular functions in perfused organs.关于灌注器官中细胞功能的位置
J Theor Biol. 1980 Feb 7;82(3):347-51. doi: 10.1016/0022-5193(80)90241-6.
5
Verapamil kinetics in normal subjects and patients with coronary artery spasm.正常受试者和冠状动脉痉挛患者的维拉帕米动力学
Clin Pharmacol Ther. 1981 Nov;30(5):644-52. doi: 10.1038/clpt.1981.216.
6
Effects of capillary heterogeneity on rates of steady uptake of substances by the intact liver.
Microvasc Res. 1981 Jul;22(1):43-57. doi: 10.1016/0026-2862(81)90110-2.
7
Functional zones in rat liver: the degree of overlap.大鼠肝脏中的功能区:重叠程度
J Theor Biol. 1981 Mar 21;89(2):303-19. doi: 10.1016/0022-5193(81)90313-1.
8
Hepatic elimination of femoxetine in pig during intravenous infusion.静脉输注期间猪体内非莫西汀的肝脏消除情况。
Acta Pharmacol Toxicol (Copenh). 1983 Mar;52(3):234-7. doi: 10.1111/j.1600-0773.1983.tb01092.x.
9
Hepatic elimination of femoxetine in pig.猪体内非莫西汀的肝脏消除
Acta Pharmacol Toxicol (Copenh). 1983 Jan;52(1):1-7. doi: 10.1111/j.1600-0773.1983.tb01067.x.
10
Predictability of verapamil steady-state plasma levels from single-dose data explained.维拉帕米稳态血浆水平单剂量数据预测性解析。
Clin Pharmacol Ther. 1984 Jul;36(1):1-4. doi: 10.1038/clpt.1984.129.